Data as of Mar 14
| -0.0124 / -3.06%|
The 1 analysts offering 12-month price forecasts for Hemispherx Biopharma Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +282.07% increase from the last price of 0.39.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.